[ad_1]
Of the 30 reports received as of March 24 inclusive, seven are related to human deaths, according to a statement from the Agency for Medicines and Health Products (MHRA) sent to the AFP news agency.
At that time, several European countries had temporarily stopped using AstraZeneca due to its possible links to blood clots. The Netherlands stopped vaccinating people under the age of 60 with the AstraZeneca vaccine on Friday after reporting five new cases of blood clots in women, including one death.
Germany made a similar decision earlier this week.
On Friday, the MHRA announced that more than 18 million people have been vaccinated in the UK. A total of 30 cases of blood clots have been reported in people who received the AstraZeneca coronavirus vaccine.
It was reported that 22 cases of cerebral venous sinus thrombosis were reported, as well as another eight cases of thrombosis were confirmed, while a decrease in platelet count was recorded.
“The risk of this particular type of blood clot is very low,” the service said Friday, urging residents to continue getting vaccinated with the AstraZeneca vaccine.
The European Medicines Agency (EMA), which, like the World Health Organization (WHO), has previously said that AstraZeneca is safe, said its safety committee should issue “updated guidelines” on the use of the controversial Vaccine on April 7.
On Wednesday, the EVA reported that experts investigating a possible link between the AstraZeneca vaccine and blood clots in vaccinated patients had found no specific risk factors, including age, sex, or other diseases, but were continuing to investigate. The Drug Control Agency reiterated its earlier statement on March 18 that the vaccine “has the benefit of protecting people from the risks of COVID-19 and its associated deaths and hospitalizations.”
The MHRA said there were no reports of blood clots after vaccination with Pfizer and BioNTech, adding that it was “thoroughly reviewing these reports.”
The regulator’s website states that, based on current data, the benefits of COVID-19 vaccines “continue to outweigh any risks.”
Last month, AstraZeneca announced that a study in the US found the vaccine to be 79 percent effective in protecting against the disease. and that it does not increase the risk of blood clots.
The UK has already used over 31 million. first doses of vaccines, including the AstraZeneca and Pfizer vaccines. People cannot choose which vaccine to vaccinate.
In June 2020, the UK asked for 100 million euros. AstraZeneca vaccine dose and supported its development. In the same year, he also ordered $ 30 million. Pfizer and BioNTech Vaccine Dosages.
[ad_2]
